Human Rotavirus Vaccine Market information by type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, others) by end users (hospitals & clinics, academic and research, others) - Forecast till 2032

Table of contents
1. Introduction

1.1 Definition

1.2 Scope of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure

2. Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3. Market dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4. Market factor analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power of Suppliers

4.3 Bargaining Power of Buyers

4.4 Threat of New Entrants

4.5 Threat of Substitutes

4.6 Intensity of Rivalry

5. Global Human Rotavirus Vaccine Market, by Type

5.1 Rotarix

5.2 Rotateq

5.3 Rotavac

5.4 Rotavin-M1

5.5 Lanzhou Lamb

5.6 Others

6. Global Human Rotavirus Vaccine Market, by End Users

6.1 Introduction

6.2 Hospitals & Clinics

6.3 Academic And Research

6.4 Others

7. Global Human Rotavirus Vaccine Market, by Region

7.1 North America

7.1.1 Introduction

7.2 Europe

7.2.1 Introduction

7.3 Asia Pacific

7.3.1 Introduction

7.4 Middle East & Africa

7.4.1 Introduction

8. Competitive landscape

8.1 Major Strategies Adopted by Market Players

8.1.1 Strategic Partnership

8.1.2 Merger & Acquisition

9. Company profile

9.1 Bharat Biotech

9.1.1 Overview

9.1.2 Product Overview

9.1.3 Financials

9.1.4 Key Developments

9.2 Merck & Co., Inc.

9.2.1 Overview

9.2.2 Product Overview

9.2.3 Financials

9.2.4 Key Developments

9.3 GlaxoSmithKline plc.

9.3.1 Overview

9.3.2 Product Overview

9.3.3 Financials

9.3.4 Key Development

9.4 Sanofi

9.4.1 Overview

9.4.2 Product Overview

9.4.3 Financials

9.4.4 Key Development

9.5 Others

10. Conclusion

10.1 Key Findings

10.1.1 From CEO’s Viewpoint

10.1.2 Unmet Needs of The Market

10.2 Key Companies to Watch

10.3 Prediction of Human Rotavirus Vaccine Industry

11. Appendix